Intermittent Fasting and Diabetes: Is It Safe?

Quick Answer: For Type 2 diabetes, intermittent fasting shows significant promise for improving insulin sensitivity, reducing blood sugar, and in some cases reducing medication requirements, but only under medical supervision. For Type 1 diabetes, fasting carries serious risks including hypoglycemia and diabetic ketoacidosis, and should only be attempted with close endocrinologist guidance and continuous glucose monitoring. Never adjust diabetes medications on your own.

IMPORTANT MEDICAL DISCLAIMER

This article is strictly for educational purposes and does not constitute medical advice. Diabetes is a serious medical condition that requires professional management. Intermittent fasting can cause dangerous blood sugar fluctuations in people with diabetes, including life-threatening hypoglycemia and diabetic ketoacidosis.

Do not start, modify, or stop any fasting protocol without direct guidance from your endocrinologist or diabetes care team. Do not adjust insulin or diabetes medication dosages based on information in this article. Individual responses to fasting vary widely, and what is safe for one person may be dangerous for another.

Intermittent fasting and diabetes share a common thread: insulin. Fasting fundamentally alters insulin dynamics, which makes it both potentially powerful and potentially dangerous for people with diabetes. The distinction between Type 1 and Type 2 diabetes is critical here, because the underlying biology, risks, and evidence differ substantially.

Type 2 Diabetes and Intermittent Fasting

The Rationale

Type 2 diabetes is characterized by insulin resistance, a condition where the body's cells respond poorly to insulin, requiring the pancreas to produce more and more insulin to maintain blood sugar control. Over time, the pancreas may become unable to keep up, leading to elevated blood sugar.

Intermittent fasting directly addresses insulin resistance through several mechanisms:

Reduced insulin exposure. During fasting, insulin levels drop significantly, giving cells a break from constant insulin stimulation and allowing insulin receptors to resensitize. Understanding how insulin works is key to understanding why fasting helps.

Improved insulin sensitivity. A small 2018 crossover trial in Cell Metabolism fed eight men with prediabetes enough to hold their weight steady, and still found that early time-restricted feeding improved insulin sensitivity, suggesting that the timing of eating itself has metabolic effects independent of caloric intake (Sutton et al., 2018).

Weight loss. Excess body fat, particularly visceral fat, drives insulin resistance. Intermittent fasting promotes fat loss while preserving lean mass, directly reducing the metabolic burden on the insulin system.

Reduced hepatic glucose output. Roy Taylor's review in Diabetes Care traces elevated fasting blood glucose in Type 2 diabetes to fat stored in the liver, and reports fasting plasma glucose normalizing within about a week of calorie restriction as liver fat falls (Taylor, 2013).

What the Research Shows

The evidence for intermittent fasting in Type 2 diabetes is growing, and it is mixed.

A 2023 randomized controlled trial published in JAMA Network Open compared time-restricted eating (8-hour window) to calorie counting in 75 adults with Type 2 diabetes. Over 6 months the time-restricted eating group lost more weight, 3.6% against 1.8%, and found the plan easier to stick to. HbA1c fell in both groups by roughly the same amount (Pavlou et al., 2023).

A 2018 case series published in BMJ Case Reports documented three patients with Type 2 diabetes who were able to discontinue insulin therapy after adopting intermittent fasting protocols under medical supervision (Furmli et al., 2018). Three patients is the weakest form of clinical evidence.

The largest pooled analysis is more sober. A 2021 meta-analysis in the Journal of Clinical Endocrinology and Metabolism combined seven trials and 338 people with Type 2 diabetes. Intermittent fasting produced modestly more weight loss than a standard diet, about 1.9 kg, but no further reduction in HbA1c (Borgundvaag et al., 2021).

Risks for Type 2 Diabetes

Despite the benefits, fasting with Type 2 diabetes carries real risks:

Hypoglycemia. This is the most immediate danger. The National Institute of Diabetes and Digestive and Kidney Diseases lists fasting while taking glucose-lowering medicines as a direct cause of low blood glucose, and names insulin, sulfonylureas (glipizide, glyburide) and meglitinides as the drugs that do it. Symptoms include shakiness, confusion, sweating, rapid heartbeat, and in severe cases, loss of consciousness.

Hyperglycemia. Paradoxically, some people experience blood sugar spikes when breaking a fast, particularly if they consume high-glycemic foods after prolonged fasting periods.

Dehydration. High blood sugar causes increased urination. Combined with fasting, dehydration risk increases, which can worsen blood sugar control.

Medication interactions. Fasting often requires medication dose adjustments. This must be done by your prescribing physician, not independently.

Safe Fasting Protocol for Type 2 Diabetes

Get medical clearance. Your doctor may need to adjust medications before you start.
Start with 16:8 or 14:10. The 2023 trial used an 8-hour window. This is the range the controlled evidence covers, not the extremes.
Monitor blood glucose frequently. Check before, during, and after fasting periods. A continuous glucose monitor is ideal.
Know your breaking points. The NIDDK puts low blood glucose at below 70 mg/dL (3.9 mmol/L). Break the fast immediately with 15 to 20 grams of fast-acting carbohydrate and recheck 15 minutes later — the 15-15 rule. Agree an upper limit with your care team before you start.
Stay hydrated. Water, black coffee, and plain tea during fasting periods.
Break your fast gently. Start with a balanced meal containing protein, healthy fat, and complex carbohydrates. Avoid large portions of refined carbohydrates.
Track side effects carefully. Report persistent symptoms to your healthcare team.

Type 1 Diabetes and Intermittent Fasting

A Fundamentally Different Situation

Type 1 diabetes is an autoimmune condition where the pancreas produces little to no insulin. People with Type 1 diabetes depend on exogenous insulin for survival. This creates a fundamentally different risk profile for fasting compared to Type 2 diabetes.

The Risks Are Higher

Hypoglycemia. Without food intake, background (basal) insulin continues to lower blood sugar. If basal insulin doses are not adjusted, dangerous hypoglycemia can occur during fasting. The EPIDIAR study, which tracked people with diabetes across 13 countries through Ramadan, recorded severe hypoglycemia in Type 1 diabetes at 0.14 episodes per person per month during the fast against 0.03 per month at other times (Salti et al., 2004).

Diabetic ketoacidosis (DKA). If insulin doses are reduced too aggressively to prevent hypoglycemia, the body can enter a state of ketoacidosis, where blood becomes dangerously acidic. DKA is a medical emergency that can be fatal.

Blood sugar volatility. The combination of fasting, insulin dosing, and refeeding creates a complex metabolic situation where blood sugar can swing unpredictably.

Can It Be Done Safely?

Some people with Type 1 diabetes do practice intermittent fasting, but it requires:

Close endocrinologist supervision
Continuous glucose monitoring (CGM)
Insulin pump or carefully adjusted multiple daily injection regimen
Education on when to break the fast
A support system for emergencies

The bottom line for Type 1 diabetes: Intermittent fasting is not recommended as a general practice. If you are interested, it must be pursued as a carefully supervised medical intervention, not a self-directed lifestyle change.

Gestational Diabetes

Intermittent fasting is generally not recommended during pregnancy, including for women with gestational diabetes. Consult your obstetrician for blood sugar management strategies during pregnancy.

Medications That Require Extra Caution

If you take any of the following medications, fasting requires dosage adjustments and close monitoring:

Insulin (all types): High hypoglycemia risk during fasting
Sulfonylureas (glipizide, glyburide, glimepiride): Stimulate insulin release regardless of food intake
Meglitinides (repaglinide, nateglinide): Similar to sulfonylureas but shorter-acting
SGLT2 inhibitors (empagliflozin, dapagliflozin): The empagliflozin label names reduced caloric intake and ketogenic diets among the conditions that can precipitate ketoacidosis, and tells prescribers to withhold the drug in situations that predispose to it

Medications like metformin, GLP-1 receptor agonists, and DPP-4 inhibitors generally have a lower hypoglycemia risk during fasting but should still be discussed with your doctor. If you take a GLP-1 receptor agonist, our guide to fasting on a GLP-1 covers where the two overlap; the dose stays with your prescriber.

How Fasted Helps

Fasted provides the structure that people with diabetes need for safe fasting. Set your 16:8 or 14:10 window and receive clear notifications for when to eat and when to stop. The weight and meal logging features help you track patterns that you can share with your diabetes care team. Consistent tracking creates the data your doctor needs to make informed medication adjustments. Combined with your glucose monitoring data, Fasted gives you a complete picture of how fasting affects your metabolic health.

Frequently Asked Questions

Can intermittent fasting reverse Type 2 diabetes?

Sustained weight loss can drive Type 2 diabetes into remission, and Taylor's work shows fasting plasma glucose normalizing as liver fat falls. Whether fasting achieves this better than any other route to the same weight loss is unsettled: the 2021 meta-analysis found no HbA1c advantage over a standard diet. The 2018 Furmli case series documented three patients discontinuing insulin after adopting fasting protocols. "Reversal" depends on the stage of disease, individual biology, and sustained lifestyle changes. It should always be pursued under medical supervision.

How often should I check my blood sugar while fasting?

During the first weeks of a new fasting protocol, check blood glucose more often than you normally would: on waking, mid-fast, before breaking the fast, and two hours after your first meal is a sensible pattern to agree with your care team. A continuous glucose monitor provides the most comprehensive data. After stabilization, your healthcare team can advise on reduced monitoring frequency.

Can I fast if I take metformin?

Metformin does not cause low blood sugar on its own, and it is generally compatible with intermittent fasting. MedlinePlus advises taking it with meals, and its common side effects — diarrhea, nausea, stomach discomfort, gas — are the reason. Take metformin with food during your eating window. Consult your prescribing physician before starting fasting.

Is fasting safe for people with both diabetes and kidney disease?

Diabetic kidney disease (nephropathy) adds complexity. Fasting affects hydration, electrolytes, and medication clearance, all of which are critical in kidney disease. People with significant kidney impairment should not fast without nephrology approval and close monitoring.